Amedeo Smart

Free Medical Literature Service


 

Amedeo

Malignant Lymphoma

  Free Subscription

19.02.2024

2 Am J Hematol
2 Bone Marrow Transplant
2 Cancer
1 Haematologica
2 J Clin Oncol
2 Leuk Lymphoma
1 Neurology



    Am J Hematol

  1. KITTAI AS, Hang Y, Bhat SA, Clark A, et al
    Racial disparities in chronic lymphocytic leukemia/small lymphocytic lymphoma accounting for small molecule inhibitors: A real-world cohort analysis.
    Am J Hematol. 2024 Feb 15. doi: 10.1002/ajh.27241.
    >> Share

  2. ONG SY, Zain JM
    Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management.
    Am J Hematol. 2024;99:439-456.
    >> Share


    Bone Marrow Transplant

  3. NAKAYA Y, Nakamae H, Nishikubo M, Kondo E, et al
    Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma.
    Bone Marrow Transplant. 2024 Feb 14. doi: 10.1038/s41409-024-02229.
    >> Share

  4. HIROSE A, Koh H, Nakamae M, Nakashima Y, et al
    A comparison of long-term outcomes by donor type in the era of post-transplantation cyclophosphamide for aggressive adult T-cell leukemia/lymphoma.
    Bone Marrow Transplant. 2024 Feb 14. doi: 10.1038/s41409-024-02231.
    >> Share


    Cancer

  5. WU S, Rhee JW, Iukuridze A, Bosworth A, et al
    Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Cancer. 2024 Feb 15. doi: 10.1002/cncr.35252.
    >> Share

  6. TZANKOV A, Tatarczuch M
    Time to Be Launched 1 auXiliary Risk strat1fier in marginal zone lymphoma transformation: TBL1XR1.
    Cancer. 2024 Feb 14. doi: 10.1002/cncr.35246.
    >> Share


    Haematologica

  7. YUAN X, Xie Y, Xu N, Liu H, et al
    Lenalidomide, rituximab, and methotrexate are effective in newly diagnosed primary central nervous system lymphoma.
    Haematologica. 2024 Feb 15. doi: 10.3324/haematol.2023.284834.
    >> Share


    J Clin Oncol

  8. CAMUS V, Thieblemont C, Gaulard P, Cheminant M, et al
    Romidepsin Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Final Analysis of the Ro-CHOP Trial.
    J Clin Oncol. 2024 Feb 16:JCO2301687. doi: 10.1200/JCO.23.01687.
    >> Share

  9. NEPPELENBROEK SIM, Geurts YM, Aleman BMP, Lugtenburg PJ, et al
    Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma.
    J Clin Oncol. 2024 Feb 15:JCO2301386. doi: 10.1200/JCO.23.01386.
    >> Share


    Leuk Lymphoma

  10. OSTERGAARD S, Schejbel L, Breinholt MF, Pedersen MO, et al
    Mutational landscape in Waldenstrom macroglobulinemia evaluated using a next-generation sequencing lymphoma panel in routine clinical practice.
    Leuk Lymphoma. 2024 Feb 10:1-10. doi: 10.1080/10428194.2024.2313623.
    >> Share

  11. BRAUNSTEIN Z, Waller A, Dotson E, McLaughlin E, et al
    Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas.
    Leuk Lymphoma. 2024;65:301-311.
    >> Share


    Neurology

  12. LI CMF, MacDougall K, Fraser JA
    Teaching NeuroImage: Transcalvarial Lymphoma: A Rare Cause of Secondary Intracranial Hypertension.
    Neurology. 2024;102:e209227.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016